Low dose Galcanezumab for treating trigeminal autonomic cephalalgias: clinical observation from Colombia and Mexico on behalf of ASOLAC. (2025). Headache Medicine, 16(1), 65-70. https://doi.org/10.48208/HeadacheMed.2025.9